GETI.B

193.7

+0.96%↑

VITR

157.7

+1.48%↑

AMBEA

107.1

+0.85%↑

ARJOB

31.18

-0.19%↓

MSON.B

8.74

0%↓

GETI.B

193.7

+0.96%↑

VITR

157.7

+1.48%↑

AMBEA

107.1

+0.85%↑

ARJOB

31.18

-0.19%↓

MSON.B

8.74

0%↓

GETI.B

193.7

+0.96%↑

VITR

157.7

+1.48%↑

AMBEA

107.1

+0.85%↑

ARJOB

31.18

-0.19%↓

MSON.B

8.74

0%↓

GETI.B

193.7

+0.96%↑

VITR

157.7

+1.48%↑

AMBEA

107.1

+0.85%↑

ARJOB

31.18

-0.19%↓

MSON.B

8.74

0%↓

GETI.B

193.7

+0.96%↑

VITR

157.7

+1.48%↑

AMBEA

107.1

+0.85%↑

ARJOB

31.18

-0.19%↓

MSON.B

8.74

0%↓

Search

Elekta AB

Closed

52.6 0.96

Overview

Share price change

24h

Current

Min

52.55

Max

52.7

Key metrics

By Trading Economics

Income

156M

431M

Sales

354M

4.7B

P/E

Sector Avg

18.971

56.602

EPS

0.94

Dividend yield

4.65

Profit margin

9.18

Employees

4,541

EBITDA

152M

849M

Dividends

By Dow Jones

Dividend yield

Sector Avg

4.65%

2.45%

Next Earnings

28 May 2025

Market Stats

By TradingEconomics

Market Cap

-3.9B

20B

Previous open

51.64

Previous close

52.6

Elekta AB Chart

Past performance is not a reliable indicator of future results.

Related News

16 May 2025, 19:39 UTC

Major Market Movers

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

17 May 2025, 09:30 UTC

Top News
Earnings

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17 May 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 May 2025, 08:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

17 May 2025, 05:30 UTC

Acquisitions, Mergers, Takeovers

Tradeweb Is Looking to Come to a Bond Market Near You -- Barrons.com

16 May 2025, 23:18 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 May 2025, 22:30 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- Update

16 May 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 May 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 May 2025, 21:54 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 May 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 May 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 May 2025, 21:17 UTC

Top News

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 May 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 May 2025, 20:55 UTC

Acquisitions, Mergers, Takeovers

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 May 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

16 May 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 May 2025, 20:37 UTC

Top News

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 May 2025, 20:33 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 May 2025, 20:30 UTC

Acquisitions, Mergers, Takeovers

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 May 2025, 20:18 UTC

Top News

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 May 2025, 20:16 UTC

Top News

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 May 2025, 20:15 UTC

Earnings

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 May 2025, 20:11 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: William K. Daniel Joins Board

16 May 2025, 20:10 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: Strategic Investment by KKR Completed

16 May 2025, 20:05 UTC

Acquisitions, Mergers, Takeovers

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 May 2025, 19:38 UTC

Market Talk

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16 May 2025, 19:07 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

16 May 2025, 18:51 UTC

Top News

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16 May 2025, 18:41 UTC

Acquisitions, Mergers, Takeovers

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

Peer Comparison

Price change

Elekta AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.